Carlos E Durán
Biographic Data
| ID | 7503518 |
|---|---|
| NAME | Carlos E Durán |
| GIVEN NAMES | Carlos E |
| FAMILY NAME | Durán |
| SIGNATURE | DURÁN C E |
| AFFILIATIONS | Ghent University Hospital |
| ORCID | 0000-0003-1853-3641 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Enhancing Vaccine Safety
Regulatory reliance to approve new medicinal products in Latin American and Caribbean countries
Regulatory reliance has become a common practice in the LAC region. Thirteen out of 20 regulators directly recognize or abbreviate the marketing authorization process in case of earlier approval by a regulator from another jurisdiction. The regulators most relied upon are the European Medicines Agency, United States Food and Drug Administration, and Health Canada
No prominent works on this page.
Regulatory reliance to approve new medicinal products in Latin American and Caribbean countries
Regulatory reliance has become a common practice in the LAC region. Thirteen out of 20 regulators directly recognize or abbreviate the marketing authorization process in case of earlier approval by a regulator from another jurisdiction. The regulators most relied upon are the European Medicines Agency, United States Food and Drug Administration, and Health Canada
Enhancing Vaccine Safety
Agency (philosophy (1 work) · Antimicrobial Resistance in Staphylococcus (1 work) · Authorization (1 work) · Biomedical Ethics and Regulation (1 work) · Biosimilars and Bioanalytical Methods (1 work) · Burden of disease (1 work) · Business (1 work) · Caribbean region (1 work) · Clostridium difficile and Clostridium perfringens research (1 work) · Disease (1 work)